JAKAFI - 50881-020-60 - (ruxolitinib)

Alphabetical Index


Drug Information of JAKAFI

Product NDC: 50881-020
Proprietary Name: JAKAFI
Non Proprietary Name: ruxolitinib
Active Ingredient(s): 20    mg/1 & nbsp;   ruxolitinib
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of JAKAFI

Product NDC: 50881-020
Labeler Name: Incyte Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202192
Marketing Category: NDA
Start Marketing Date: 20111116

Package Information of JAKAFI

Package NDC: 50881-020-60
Package Description: 60 TABLET in 1 BOTTLE, PLASTIC (50881-020-60)

NDC Information of JAKAFI

NDC Code 50881-020-60
Proprietary Name JAKAFI
Package Description 60 TABLET in 1 BOTTLE, PLASTIC (50881-020-60)
Product NDC 50881-020
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ruxolitinib
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20111116
Marketing Category Name NDA
Labeler Name Incyte Corporation
Substance Name RUXOLITINIB
Strength Number 20
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of JAKAFI


General Information